The Importance of the Inter-Professional Team and Shared-Decision Making

This module of the Eight-Part Cystic Fibrosis Interview Series highlights the inter-professional team and their important role in treating the CF patient. Debbie Benitez RN, MSN, ACNP-BC will discuss with Dr. John P. Clancy the various health care professionals that impact the care of CF patients. She will explain how a mental health coordinator, physical therapist, and pharmacist contribute to the overall health and well-being of CF patients. Cystic fibrosis is a complex disease and a collaborative approach based on shared-decision making is critical in moving forward with patient care. 

TARGET AUDIENCE

These activities are designed for physicians, nurses, and other healthcare professionals involved in the management of patients with cystic fibrosis.

LEARNING OUTCOME STATEMENTS

At the conclusion of this activity:

KNOWLEDGE: Participants will self-report knowledge gained based on best practices for using shared decision making when treating patients with cystic fibrosis.

COMPETENCE/SKILL: Participants will self-report intent to change practice by applying a collaborative approach during the management and care of patients with cystic fibrosis.

EDUCATIONAL OBJECTIVES

Upon completion of this activity, participants will be better able to do the following:

  1. Utilize the inter-professional team and shared-decision making when treating patients with CF

FACULTY

John P. Clancy, MD (Chair)
Professor of Pediatrics
Director, Pulmonary Medicine Research
Co- Director, CF Research Development Program
Medical Director, Office of Clinical and Translational Research
Gunnar Esiason/Cincinnati Bell Chair in Life Sciences Research
Division of Pulmonary Medicine
Cincinnati Children’s Hospital Medical Center
Cincinnati, Ohio

Debbie S. Benitez, RN, MSN, ACNP-BC
Pulmonary Nurse Practitioner/Nurse Coordinator
Center for Cystic Fibrosis
Keck Medical Center of USC
Los Angeles, California

Disclosure of Conflicts of Interest

It is the policy of the Elsevier Office of Continuing Medical Education and Elsevier ANCC accredited provider  that all faculty, instructors, and planners disclose real or apparent conflicts of interest relating to the topics of this educational activity. 

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

FacultyRelationship Identified With:
John P. Clancy, MD

Consultant/Advisor: Gilead

Grant/Research Support: Bayer AG, Concert Pharmaceuticals, Inc., Vertex Pharmaceuticals Incorporated, ProQR Therapeutics

Speaker's Bureau: Genentech, Inc.

Debbie S. Benitez, RN, MSN, ACNP-BC

Consultant/Advisor: Gilead; Vertex Pharmaceuticals Incorporated

Speaker's Bureau: Gilead

Non-faculty: Sandy Breslow; Alison Kemp; Marilu Kelly, MSN, RN, CNE; Bernard M. Abrams, MD; Timothy Hayes, MD, PhD; Emma Boring; Nicole Brestowski and Chelsey Benedek hereby state that neither they nor their spouse/life partner have any financial relationships to products or devices with any commercials interest related to the content of this activity of any amount during the past 12 months.

Financial Support

This activity has been supported by an independent educational grant from Vertex Pharmaceuticals Incorporated.

PROVIDER INFORMATION

Provided in collaboration with the Elsevier Office of Continuing Medical Education, Elsevier and AcademicCME.

CME CREDIT (PHYSICIANS)

The Elsevier Office of Continuing Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for physicians.

The Elsevier Office of Continuing Medical Education designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE CREDIT (NURSES)

This continuing nursing education activity, provided by Elsevier, awards 0.46 contact hours for nurses. Elsevier is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Elsevier is provider approved by the Florida Board of Nursing, Provider #50-4681, and the California Board of Registered Nursing, Provider #CEP 3257.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of EOCME, Elsevier, and AcademicCME. EOCME is accredited by the ACCME to provide continuing medical education for physicians.

CME/CNE INQUIRIES/SPECIAL NEEDS

For all CME inquiries or special needs, please contact elsevierCME@elsevier.com.

For all CNE inquiries or special needs, please contact p.harvey@elsevier.com.


Disclosure of Unlabeled Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Elsevier Office of Continuing Medical Education, Elsevier, AcademicCME and Vertex Pharmaceuticals Incorporated. do not recommend the use of any agent outside of the labeled indications. 

Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Course summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit(s)™
  • 0.46 Nursing Contact Hours
  • 0.50 Non-physician
Course opens: 
09/15/2017
Course expires: 
09/14/2018
Rating: 
0

Available Credit

  • 0.50 AMA PRA Category 1 Credit(s)™
  • 0.46 Nursing Contact Hours
  • 0.50 Non-physician

Accreditation Period

Course opens: 
09/15/2017
Course expires: 
09/14/2018
Please login or register to take this course.